High-quality chest CT segmentation to assess the impact of COVID-19 disease - Summary - MDSpire

High-quality chest CT segmentation to assess the impact of COVID-19 disease

  • By

  • Michele Bertolini

  • Alma Brambilla

  • Samanta Dallasta

  • Giorgio Colombo

  • August 6, 2021

  • 0 min

Share

Objective:

To implement a method for 3D segmentation from CT scans to demonstrate the pathological effects of COVID-19 and assist in both diagnosis and monitoring of CT findings.

Key Findings:
  • CT imaging can help in the presumptive diagnosis and monitoring of COVID-19, providing critical insights into disease progression.
  • Common CT manifestations include ground-glass opacities and bilateral abnormalities, which are crucial for clinical assessment.
  • Manual segmentation is time-consuming and variable, leading to the exploration of automatic methods to enhance consistency and speed.
Interpretation:

While CT imaging provides valuable insights into COVID-19 pathology, its diagnostic accuracy is limited and may overlap with other diseases, complicating clinical decision-making.

Limitations:
  • CT findings are non-specific and may not definitively indicate COVID-19.
  • Diagnostic accuracy depends on reader experience and criteria used, which can vary significantly.
  • The bidimensional nature of CT can complicate accurate measurements.
Conclusion:

The study highlights the potential of 3D segmentation techniques to enhance the assessment of COVID-19 impacts through volumetric quantification.

Original Source(s)

Related Content